C. Kong

发表

Corticosteroid administration for cancer-related indications is an unfavorable prognostic factor in solid cancer patients receiving immune checkpoint inhibitor treatment.

Xudong Yin, Xuebing Yan, Hao Li, 2021, International immunopharmacology.

LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma

Tsair-Fwu Lee, Xia He, C. Kong, 2016, Scientific Reports.

Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.

C. Kong, Jin-Cheng Lu, H. Tao, 2010, International journal of radiation oncology, biology, physics.

Antibiotic administration shortly before or after immunotherapy initiation is correlated with poor prognosis in solid cancer patients: An up-to-date systematic review and meta-analysis.

Xuebing Yan, Hao Li, Mingyang Tao, 2020, International immunopharmacology.

Association of Blood Biochemical Indexes and Antibiotic Exposure With Severe Immune-related Adverse Events in Patients With Advanced Cancers Receiving PD-1 Inhibitors

L. Yin, Lijun Zhao, Xia He, 2022, Journal of immunotherapy.

Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report

G. Deng, Wan He, C. Kong, 2018, OncoTargets and therapy.

Survival and Toxicity of Hypofractionated Intensity-Modulated Radiotherapy in 4-Gy Fractions for Unresectable Stage III Non-Small-Cell Lung Cancer.

Lijun Zhao, Xia He, M. Shi, 2020, International journal of radiation oncology, biology, physics.

A dose volume analysis of brain stem injury after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma

Xia He, C. Kong, Chengyun Yao, 2017 .

Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.

D. Dearnaley, K. Harrington, C. Clark, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Long-term outcomes in patients with central and ultracentral non-small cell lung cancer treated with stereotactic body radiotherapy: single-institution experience.

N. Zhang, Lijun Zhao, N. Jiang, 2023, Current problems in cancer.

Association of red cell distribution width with the risk of 3-month readmission in patients with heart failure: A retrospective cohort study

Fang Gu, Xiao Jin, Wenyan Zhao, 2023, Frontiers in Cardiovascular Medicine.

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer

Guolin Zhong, Shifu Chen, Ming Liu, 2018, Oncology letters.

SCALE-1: Safety and efficacy of short course neoadjuvant chemo-radiotherapy plus toripalimab for locally advanced resectable squamous cell carcinoma of esophagus.

Si Li, Bin-hui Ren, Lijun Zhao, 2022, Journal of Clinical Oncology.

Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT‐based radiomics signature

Feng Chen, Siwei Wang, Zhifei Ma, 2019, Thoracic cancer.

A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer: analysis of data from the literature.

Cheng Kong, Xia He, Wen-jie Guo, 2014, Lung cancer.

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment

Lijun Zhao, C. Kong, Jian-hua Xu, 2023, Frontiers in Oncology.